Authors: Majewski, Slawomir; Kutner, Andrzej; Jablonska, Stefania

Source: Current Pharmaceutical Design, Volume 6, Number 7, May 2000 , pp. 829-838(10)

Publisher: Bentham Science Publishers

Abstract:

In this article are reviewed available experimental and clinical studies on vitamin D analogs, and molecular and cellular mechanisms of their antineoplastic activity. In more detail are discussed the antiproliferative and pro-differentiative effects, inhibition of tumor-induced angiogenesis and induction of apoptosis. The use of vitamin D analogs is however hampered by their toxicity. In various experimental systems it was shown that the activities of vitamin D analogs can be enhanced by combined application with retinoids or other biological active compounds, such as cytokines and growth factors. Retinoids and vitamin D analogs were found to have synergistic inhibitory effects on tumor cell proliferation and angiogenic capability, and both agents applied simultaneously are efficacious in small doses. Thus combined therapy could find application in clinical practice. There are up to now only very limited data on the treatment of cutaneous malignancies with vitamin D analogs, and it appears that a combined therapy, preferably with retinoids, could be more beneficial. The new synthetic, more potent and less calcemic analogs might find wide application in chemotherapy of premalignant and early malignant cutaneous tumors, and could be especially useful for chemoprevention in the high-risk groups, eg. xeroderma pigmentosum, organ transplant recipients, arsenical keratoses and others.

Keywords: Vitamin D Analogs; Cutaneous Malignancies; Cell Proliferation; receptor VDR; JCA 1 cell line; MCF6; DMBA; Cervical Tumors; Transglutaminase K; Cytokeratin 10; Ki 60; Immortalized keratinocyte HPKIA; Cancer; Immunosuppressive; Angiogenesis; Retinoids; Cytokines

Document Type: Research article

Affiliations: 1: Department of Dermatology and Venereology, Warsaw School of Medicine, Koszykowa 82A, 02-008 Warsaw, Poland

Publication date: 2000-05-01

More about this publication?

• Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.
  
  Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Related content

• In this: publication
• By this: publisher
• In this Subject: Pharmacology
• By this author: Majewski, Slawomir ;  Kutner, Andrzej ;  Jablonska, Stefania

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers